Hove Anders D
SEC-identified person · CIK 1365618 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Reneo Pharmaceuticals, Inc. RPHM | Officer | filed 2024–2025 |
| Oruka Therapeutics, Inc. ORKA | Director | filed 2015–2024 |
| Inspire Medical Systems, Inc. [INSP | Officer | filed 2018–2018 |
| Anacor Pharmaceuticals, Inc. ANAC | Director | filed 2010–2016 |
| PDS Biotechnology Corp PDSB | Director | filed 2015–2015 |
| Avalanche Biotechnologies, Inc. [AAVL] | Officer | filed 2014–2014 |
| Ironwood Pharmaceuticals INC IRWD | Officer | filed 2010–2013 |
| World Heart Corp whrt | Director | filed 2009–2012 |
| Chelsea Therapeutics International, Ltd. CHTP.OB | Officer | filed 2010–2011 |
| Trubion Pharmaceuticals, Inc TRBN | Director | filed 2006–2010 |
| Alimera Sciences INC ALM | Director | filed 2010–2010 |
| Neurocrine Biosciences INC NBIX | Officer | filed 2010–2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.